Acute Kidney Injury in Patients With CoVID-19

The Effect of Acute Kidney Injury on Prognosis in Patients Hospitalised for COVID-19.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04872764

Acronym

AKI-COVID-19

Enrollment

600

Registered

2021-05-04

Start date

2020-03-20

Completion date

2020-12-20

Last updated

2021-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Covid19

Brief summary

We aimed to investigate the effect of Acute Kidney Injury (AKİ) on the prognosis of patients hospitalised for COVID-19.

Detailed description

The effect of Acute Kidney Injury (AKİ) on the prognosis of patients hospitalised for COVID-19. Patients hospitalised for COVID-19 and acute kidney injury will be enrolled. The duration of hospitalisation, mortality rates will be compared in COVID-19 patients with and without acute kidney injury.

Interventions

OTHERduration of hospitalization, mortality rate

duration of hospitalization, mortality rates of patients hospitalised for COVID-19 evaluated and compared in patients with and without acute kidney injury.

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Inclusion criteria

* Patients hospitalised with COVID-19. * Patients hospitalised with COVID-19 with Acute Kidney Injury

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
mortality rate	6 months	mortality rates of COVID-19 patients with and without Acute Kidney Injury
duration of hospitalisation	6 months	time between admission to hospital and discharge for COVID-19 patients with and without Acute Kidney Injury

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026